Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy

Journal of NeuroVirology

Volumn 5, Issue 4, 1999, Pages 421-429

  Gasnault, Jacques ^a,b,c   Taoufik, Yassine ^a   Goujard, Cécile ^a,b   Kousignian, Pascale ^a   Abbed, Karim ^a,b   Boue, François ^a   Dussaix, Elisabeth ^a,b   Delfraissy, Jean François ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

AntiHIV agents; Cidofovir; Demyelination; HIV; JCV; PML

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; INDINAVIR; NELFINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; FEMALE; HUMAN; JC VIRUS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SURVIVAL; VIRUS LOAD;

EID: 0032801898     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909029483     Document Type: Article

References (39)

1. Albrecht H, Hoffmann C, Degen O, et al (1998). Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12: 11491154.
2. Andrei G, Snocck R, Vandeputte M, de Clercq E (1997). - Activities of various compounds against murine and primate polyomavimses. Antimicrob Agents Chemoth 41: 587-593.
3. Antinori A, Ammassari A, De Luca A, et al (1997). Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combination with polymerase chain reaction assays in CSF. Neurology 48: 687-694.
4. 4+ T cell homeostasis and function in advanced HIV disease. Science 277: 112-116.
5. Baqi M, Kucharczyk W, Walmsley SI (1997). Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 11: 15261527.
6. Berger JR, Kaszovitz B, Post JD, Dickinson G (1987). Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literaure with a report of sixteen cases. Ann Int Med 107, 78-87.
7. Berger JR, Concha M (1995). Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J Neurovirol 1: 5 -18.
8. Berger JR, Pall L, Lanska D, Whiteman M (1998a). Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 4: 59-68.
9. Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998b). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neural 44: 341-349.
10. Brooks BR, Walker DL (1984). Progressive multifocal leukoencephalopathy. Neural Clinics 2: 299-313.
11. Brosgard C, Roberts T, Safrin S, Marra CM, Colson N, Jaffre HS (1997). Cidofovir therapy for progressive multifocal leukoencephalopathy in two AIDS patients (abstract). 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada.
12. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A (1997). Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by polymerase chain reaction. AIDS 11: 1 17. /
13. Cinque P, Casari S, Bertelli D (1998). Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. New Engl J Med 339: 838-849.
14. Clifford D and Neurologic AIDS Research Consortium (1998). Natural history of progressive multifocal leukoencephalopathy (PML) in AIDS modified by antiretroviral therapy. J Neurovirol 4: 346.
15. Domingo P, Guardiola JM, Iranzo A, Margall N (1997). Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy. Lancet 349: 1554 1555.
16. Elliott B, Aromin I, Gold R, Flanigan T, Mileno M (1997). 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Lancet 349: 850.
17. Fong IW, Toma E and the Canadian PML study group (1995a). The natural history of progressive multifocal leukoencephalopathy. Clin Infect Dis 20: 1305-1310.
18. Fong I\V, Britton CV, Luinstra KK, Toma E, Mahony JB (1995b). Diagnostic value of detecting virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 33: 484-486.
19. Gibson PE, Knowles WA, Hand JF, Brown DWG (1993). Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Med Virol 39: 278-281.
20. Gillepsie SM, Chang Y, Lemp G, et al (1991). Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco 1981-1989. Ann Neural 30: 597-604.
21. Hall CD, Dafni U, Simpson D and the AIDS Clinical Trial Group 343 Team (1998a). Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AT Eng ] Med 338: 1345-1351.
22. Hall CD, Yiannoutsos C, Clifford DB (1998b). Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. Reply. A'eir EngI J Med 339: 848-849.
23. Holman RC, Janseen RS, Buehler JW, Zelasky MT, Hooper \VC (1991). Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance. Neurology 41: 1733-1736.
24. Hou J, Major EO (1998). The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4: 451-456.
25. Huang SS, Skolasky GJ, Dal Pan, Royal W, McArthur JC (1998). Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-Interferon: an observational study. J Neurovirol 4: 324-332.
26. Krupp LB, Lipton RB, Swerdlow ML, Leeds NE, Llena J (1985). Progressive multifocal leukoencephalopathy: clinical and radiographie features. Ann Neural 17: 344-349.
27. Kurtzke JF (1983). Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
28. Major EO, Ault GS (1995). Progressive multifocal leukoencephalopathy: clinical and laboratory observations on a viral induced demyelinating disease in the immunodeficiency patient. Curr Opin Neural 8: 184 190.
29. Matheron S, Girard PM, Duval X, Petitdidier C, Bortolotti . V, Gasnault J (1998). Evaluation of cidofovir for progressive multifocal leukoencephalopathy (abstract). 5th Conference on Retroviruses and Opportunistic Infection. Chicago, USA. '
30. McGuire D, Barhite S, Hollander H, Miles M (1995). JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann Neural 37: 395-399.
31. Miller J, Barrett R, Britton C (1982). Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. New Engl J Med 307: 1436-1438.
32. Moret H, Guichard M, Matheron S, et al (1993). Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients. J Clin Microbiol 31: 3310-3313.
33. Power C, Math A, Aoki FY, Del Bigio M (1997). Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 330: 661-662.
34. Sadler M, Chinn R, Healy J, Fisher M, Nelson MR, Gazzard BG (1998). New treatments for progressive multifocal leukoencephalopathy in HIV-1 infected patients. AIDS 12: 533-535.
35. Taoufik Y, Froger D, Benoliel S, et al (1998a). Quantitative Elisa-polymerase chain reaction at saturation using homologous internal DNA standards and chemiluminescence revelation. EUT Cytokine Network 9: 197-204.
36. Taoufik Y, Gasnault J, Karaterki A, et al (1998b). Prognostic value of JC Virus load in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Infect Dis 178: 1816-1820.
37. Von Einsiedel RVV, Fifo TD, Aksamit AJ, et al (1993). Progressive multifocal leukoencephalopathy in AIDS: a clinicopathological study and review of the literature. J Neural 240: 391-406.
38. Weber T, Turner RVV, Frye S, et al (1994). Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J Infect Dis 169: 1138-1141.
39. Weber T, Frye S, Bodemer M, Otto M, Luke W (1996). Clinical implications of nucleic acid amplification methods for the diagnosis of viral infections of the nervous system. J Neurovirol 2: 175-190.